ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Cellectis Nom Eo 05

Cellectis Nom Eo 05 (ALCLS)

1.538
0.034
( 2.26% )
Updated: 05:08:00

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
1.538
Bid
1.532
Ask
1.54
Volume
11,708
1.528 Day's Range 1.546
1.414 52 Week Range 3.025
Market Cap
Previous Close
1.504
Open
1.528
Last Trade
1
@
1.538
Last Trade Time
05:08:57
Financial Volume
-
VWAP
-
Average Volume (3m)
62,105
Shares Outstanding
45,874,895
Dividend Yield
-
PE Ratio
-0.69
Earnings Per Share (EPS)
-2.2
Revenue
9.24M
Net Profit
-101.06M

About Cellectis Nom Eo 05

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Paris, Paris, Fra
Founded
-
Cellectis Nom Eo 05 is listed in the Pharmaceutical Preparations sector of the Euronext with ticker ALCLS. The last closing price for Cellectis Nom Eo 05 was 1.50 €. Over the last year, Cellectis Nom Eo 05 shares have traded in a share price range of 1.414 € to 3.025 €.

Cellectis Nom Eo 05 currently has 45,874,895 shares outstanding. The market capitalization of Cellectis Nom Eo 05 is 69.00 € million. Cellectis Nom Eo 05 has a price to earnings ratio (PE ratio) of -0.69.

ALCLS Latest News

Monthly information on share capital and company voting rights

Monthly information on share capital and company voting rights (Article 223-16 of General Regulation of the French financial markets authority)PARIS, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Listing...

Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers)PARIS, 08...

Cellectis announces the drawdown of the third tranche of €5 million under the credit facility agreement entered with the European Investment Bank (EIB)

Cellectis announces the drawdown of the third tranche of €5 million under the credit facility agreement entered with the European Investment Bank (EIB) NEW YORK, Dec. 10, 2024 (GLOBE NEWSWIRE...

Cellectis announces the drawdown of the third tranche of €5 million under the credit facility agreement entered with the European Investment Bank (EIB)

NEW YORK, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS – NASDAQ: CLLS) (the “Company”), a clinical-stage biotechnology company using its pioneering gene-editing platform...

Cellectis annonce le tirage de la troisième tranche de 5 millions d’euros dans le cadre du contrat de crédit conclu avec la Banque Européenne d’Investissement (BEI)

Cellectis annonce le tirage de la troisième tranche de 5 millions d’euros dans le cadre du contrat de crédit conclu avec la Banque Européenne d’Investissement (BEI) NEW YORK , 10 déc. 2024...

Monthly information on share capital and company voting rights

Monthly information on share capital and company voting rights (Article 223-16 of General Regulation of the French financial markets authority)PARIS, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Listing...

Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers)PARIS, 04...

Monthly information on share capital and company voting rights

Monthly information on share capital and company voting rights (Article 223-16 of General Regulation of the French financial markets authority)PARIS, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Listing...

Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers)PARIS, 06 nov...

Cellectis Presents Multiple Strategies to Enhance CAR T-cell Efficacy in Solid Tumors at the SITC Annual Meeting

NEW YORK, Nov. 05, 2024 (GLOBE NEWSWIRE) --  Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.212-12.11428571431.751.751.504525281.56936819DE
40.0583.918918918921.482.081.442975101.73203378DE
12-0.232-13.10734463281.772.081.414621051.73191249DE
26-0.358-18.88185654011.8962.171.414502141.81887524DE
52-0.882-36.44628099172.423.0251.414726252.19818556DE
156-4.397-74.08593091835.9356.0450.8881587022.76979745DE
260-14.922-90.656136087516.4628.450.8881421056.39308975DE

ALCLS - Frequently Asked Questions (FAQ)

What is the current Cellectis Nom Eo 05 share price?
The current share price of Cellectis Nom Eo 05 is 1.538 €
How many Cellectis Nom Eo 05 shares are in issue?
Cellectis Nom Eo 05 has 45,874,895 shares in issue
What is the market cap of Cellectis Nom Eo 05?
The market capitalisation of Cellectis Nom Eo 05 is EUR 69M
What is the 1 year trading range for Cellectis Nom Eo 05 share price?
Cellectis Nom Eo 05 has traded in the range of 1.414 € to 3.025 € during the past year
What is the PE ratio of Cellectis Nom Eo 05?
The price to earnings ratio of Cellectis Nom Eo 05 is -0.69
What is the cash to sales ratio of Cellectis Nom Eo 05?
The cash to sales ratio of Cellectis Nom Eo 05 is 7.6
What is the reporting currency for Cellectis Nom Eo 05?
Cellectis Nom Eo 05 reports financial results in USD
What is the latest annual turnover for Cellectis Nom Eo 05?
The latest annual turnover of Cellectis Nom Eo 05 is USD 9.24M
What is the latest annual profit for Cellectis Nom Eo 05?
The latest annual profit of Cellectis Nom Eo 05 is USD -101.06M
What is the registered address of Cellectis Nom Eo 05?
The registered address for Cellectis Nom Eo 05 is 8 RUE DE LA CROIX- JARRY, PARIS, PARIS, 75013
What is the Cellectis Nom Eo 05 website address?
The website address for Cellectis Nom Eo 05 is www.cellectis.com
Which industry sector does Cellectis Nom Eo 05 operate in?
Cellectis Nom Eo 05 operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ALMASMastrad
0.0208 €
(112.24%)
14.94M
HYPDSHipay Group DS
0.016 €
(45.45%)
72.79k
GNROGeNeuro SA
0.1835 €
(35.93%)
485.58k
ALECPEuropacorp
0.395 €
(16.18%)
178.02k
DRVDSDrone Volt DS
0.001 €
(11.11%)
77.53k
ALBIOBiosynex
1.666 €
(-17.52%)
41.48k
ALVETEGEIRO Pharma
0.0902 €
(-17.25%)
1.45k
POXELPoxel
0.326 €
(-16.52%)
2.19M
ALALOAcheterLouerFR
0.0502 €
(-14.92%)
44.43k
PROACProactis SA
0.06 €
(-13.67%)
7k
ATOAtos SE
0.0022 €
(0.00%)
146.87M
BCPBanco Comercial Portugues SA
0.5138 €
(0.27%)
25.48M
ALCYBCybergun
0.0001 €
(0.00%)
15.68M
ALMASMastrad
0.0208 €
(112.24%)
14.94M
ALVERVergnet
0.0015 €
(7.14%)
4.06M

Discussion

View Full Feed
Iggy_Bot Iggy_Bot 4 minutes ago
The mid terms should be fun
MasterBlastr MasterBlastr 5 minutes ago
Cool . . . we're up to 12 strong now.
Hi_Lo Hi_Lo 6 minutes ago
Wow! You're the first poster I have ever seen who is followed by 0 (as of today).

That makes a lot of sense.
CNNA
bunda bunda 6 minutes ago
Including you. And you still here waiting for free money from the chinee man call your father. Keep waiting for your daddy to save you
IGPK
DruidOracle55 DruidOracle55 9 minutes ago
its over.
AXXA
sab63090 sab63090 10 minutes ago
Mufaso:

Amico mio di Buffalo! Go Bills!!!!

Yeah, how do they get away with that?

Let's hope that China will learn from the USA that they can't continue to steal things (Panama Canal and biotech ideas)....they will pay for that through penalties of some
subslover subslover 11 minutes ago
Let it get sloppy like last time. 🤣
PHIO
tw0122 tw0122 12 minutes ago
Wild card as may be bottoming JAGX .86 tiny floater and PEPG $2.08 phase 2 DMD..

Many others to consider some Trump AI Stargate related  APLD AI  style="font-family: system-ui; font-size: 17px"SIDU LUNR HOVR  style="font-family: system-ui; font-size: 17px"  style="font-f
AMPG APLD BFRG
jeunke22 jeunke22 12 minutes ago
Bitcoin is again on the US political agenda, Maybe interesting to see the main infrastructural challenges for bitcoin which are complicating, and and are on top of, current AI challenges for extended bandwidth, low latency and growing power consumption,
Scalability: Crypto blockchain has a l
LWLG
S-BEES-BUMBLEBEE S-BEES-BUMBLEBEE 18 minutes ago
Added 3x yesterday & bid in for a few more. $TANH
TANH
Money hunt Money hunt 19 minutes ago
He’s buying FOXO AI Epigenetics Vithar machine for the clinical revolution
FOXO
mwab52 mwab52 19 minutes ago
Good morning (RNVA-Land & Team)......🤑😎........Go (RNVA & Team)
RNVA
CanItBThisEZ2Make CanItBThisEZ2Make 20 minutes ago
BEST SELLERS RANK (BSR) IS 725 16 Estimated Sold on Amazon Since JAN 1 - 1ST Quarter 2025
https://investorshub.advfn.com/uimage/uploads/2024/4/24/cnxttVOS_5G_GIF.gif
https://www.amazon.com/Vos-RDGL5GX55-B-01-VOS-5G-Dongle/dp/B0C66KHZLP

NOTE: In theory, when BSR Value Dec
SRMX
Fiberrevo9 Fiberrevo9 27 minutes ago
More than fibers!'.......".....capital necessary to continue production expansion for its revolutionary recombinant spider silk fibers and MATERIALS."
KBLB
diggitydoodle diggitydoodle 29 minutes ago
Different day, but for this ticker...not a single thing pointing to anything different. Unless you count the..."almost", "imminent" and we're close" schticks that are now running 3 years strong!
GLTA!
RNVA!!$$???????????????????????
RNVA
sab63090 sab63090 30 minutes ago
rayovac812

Thanks for your reply as you did address my 2 questions! I only got negative emoji's from George and those not approving of my questions for which I had no reply until yours.

The proof might be no attempt at all to do any sort of ongoing confirming trial pri
AVXL
Investor2014 Investor2014 30 minutes ago
So many misconceptions - be investors, which means take a step back, do the research on how things actually work, keep an open mind plus be a bit sceptical. It helps.

FDA signed off - no. 58 peer reviewers - no. etc. etc.
AVXL
Golden Cross Golden Cross 39 minutes ago
$ASII Huge Merger/Acquisition news should be soon. Buying .0005's... it wont be in Trips once we get news if it is big like people expect here...
ASII
Golden Cross Golden Cross 40 minutes ago
$ASII Huge Merger/Acquisition news should be soon. Buying .0005's... it wont be in Trips once we get news if it is big like people expect here...
ASII
HappyAlways HappyAlways 42 minutes ago
Trending up mainly with occasional 30% drop and up again higher. That's what I observe in the last 2-3 cycles. Anyway, I expect to see Fannie running through $10 very soon. 
FNMA
dws dws 43 minutes ago
Company Release - 1/22/2025
IDCC
GameStop GameStop 44 minutes ago
The SEC file for the Lionsgate agreement was filed on January 4, 2024 on the SEC's official website at this address

Report Date February 27, 2024

The rest is just opinion

https://www.sec.gov/edgar/search/#/ciks=0001408276&entityName=Seven%2520Arts%2520
SAPX
stervc stervc 54 minutes ago
Truenorth2016, with GCAN, to add about Quantum Computing...

I think it's a good thing that you are here in GCAN. I wasn't going to speak much about Quantum Computing, but since you brought it up, I'll share a little extra due diligence (DD) as some food for thought for those who might
GCAN
StayHumble StayHumble 1 hour ago
"I ShortNaked🔥24/7" tops the list per X MorganStanleyEmployee
“Gaming Wall Street”- HBO Documentary


Ex Morgan Stanley employee explains the situation about shorting and naked shorting perfectly!


Again, this is a MUST WATCH video for
AlwaysOptimistic AlwaysOptimistic 1 hour ago
Wikipedia says he is Taiwanese American. Makes more sense why he may have chosen to visit at this time.
IONQ

Your Recent History